Registration No. 33- ____________
As filed with the Securities and Exchange Commission on March __, 1994
==============================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------------
FORM S-8
REGISTRATION STATEMENT <F1>
Under
THE SECURITIES ACT OF 1933
-----------------------
BRISTOL-MYERS SQUIBB COMPANY
(Exact name of issuer as specified in its charter)
Delaware 22-0790350
(State of Incorporation) (I.R.S. Employer Identification No.)
345 Park Avenue
New York, New York 10154
(212) 546-4000
(Address and telephone number of principal executive offices)
BRISTOL-MYERS SQUIBB COMPANY
1983 STOCK OPTION PLAN
(AS AMENDED AND RESTATED AS OF JANUARY 1, 1993)
(Full title of Plan)
-------------------------------
Rodolphe Hamel, Vice President and General Counsel
Bristol-Myers Squibb Company
345 Park Avenue
New York, New York 10154
(212) 546-4000
(Name, address and telephone number of agent for service)
----------------------------
Copies to:
Winthrop, Stimson, Putnam & Roberts
One Battery Park Plaza
New York, New York 10004-1490
(212) 858-1000
Attention: Susan P. Serota, Esq.
---------------------------
CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>
Proposed Maximum Proposed Maximum
Amount to be Offering Price Per Aggregate Offering Amount of Registration
Title of Securities to be Registered Registered Share<F2> Price<F2> Fee <F2>
<S> <C> <C> <C> <C>
Common Stock, par value $.10 per 15,000,000 $54.9375 $824,062,500 $284,161.4
share . . . . . . . . . . . . . . .
- ------------------------------
<FN>
<F1> This Registration Statement also pertains to Rights to Purchase shares
of Series A Participating Preferred Stock of the Registrant (the
"Rights"). Until the occurrence of certain prescribed events, the
Rights are not exercisable, are evidenced by the certificates for
Bristol-Myers Squibb Company Common Stock and will be transferred along
with and only with such securities. Thereafter, separate Rights
certificates will be issued representing one Right for each share of
Bristol-Myers Squibb Company Common Stock held subject to adjustment
pursuant to anti-dilution provisions.
<F2> Pursuant to Rule 457(h) and Rule 457(c), the maximum offering price per
share and the registration fee are based on the reported average of the
high and low prices for Bristol-Myers Squibb Company Common Stock on the
New York Stock Exchange on March 10, 1994.
</TABLE>
===========================================================================
<PAGE>
PART I
INFORMATION REQUIRED IN A SECTION 10(a) PROSPECTUS
Item 1. Plan Information
Item 2. Registrant Information and Employee Plan Annual Information
PART II
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents which have heretofore been filed by Bristol-
Myers Squibb Company (the "Company") (File No. 1-1136) with the Securities
and Exchange Commission (the "Commission") pursuant to the Securities
Exchange Act of 1934, as amended (the "1934 Act"), are incorporated by
reference herein and shall be deemed to be a part hereof:
1. The Company's Annual Report on Form 10-K for the fiscal year
ended December 31, 1992.
2. The Company's Reports on Form 8-K dated June 2, 1993 and June
4, 1993.
3. The Company's Quarterly Reports on Form 10-Q for the quarters
ended March 31, 1993, June 30, 1993, and September 30, 1993.
4. The description of the Company's Common Stock contained in a
Registration Statement filed under the 1934 Act, including any amendment
or report filed for the purpose of updating such description.
5. The description of the Company's Rights contained in the
Company's Registration Statement on Form 8-A filed with the Commission
pursuant to Section 12(b) of the 1934 Act on December 10, 1987, as
amended by an amendment on Form 8 dated July 27, 1989.
All documents, filed by the Company with the Commission pursuant to
Sections 13(a), 13(c), 14 and 15(d) of the 1934 Act prior to the filing of a
post-effective amendment to this Registration Statement which indicates that
all securities offered have been sold or which deregisters all securities
then remaining unsold shall be deemed to be incorporated by reference in this
Registration Statement and made a part hereof from their respective dates of
filing (such documents, and the documents enumerated above, being hereinafter
referred to as "Incorporated Documents"); provided, however, that the
documents enumerated above or subsequently filed by the Company pursuant to
Sections 13(a), 13(c), 14 and 15(d) of the 1934 Act in each year during which
the offering made by this Registration Statement is in effect prior to the
filing with the Commission of the Company's Annual Report on Form 10-K
covering such year shall not be Incorporated Documents or be incorporated by
reference in this Registration Statement or be a part hereof from and after
the filing of such Annual Report on Form 10-K.
<PAGE>
Any statement contained in an Incorporated Document shall be deemed to
be modified or superseded for purposes of this Registration Statement to the
extent that a statement contained herein or in any other subsequently filed
Incorporated Document modifies or supersedes such statement. Any such
statement so modified or superseded shall not be deemed, except as so
modified or superseded, to constitute a part of this Registration Statement.
Item 4. Description of Securities.
See Item 3.
Item 5. Interests of Named Experts and Counsel.
The legality of the Common Stock offered pursuant to the Registration
Statement has been passed upon for the Company by Rodolphe Hamel, Vice
President and General Counsel of the Company, 345 Park Avenue, New York, New
York 10154. Mr. Hamel owns, and has options to purchase, common stock of the
Company.
Item 6. Indemnification of Directors and Officers.
Section 145 of the Delaware General Corporation Law (the "DGCL")
provides that a corporation may indemnify directors and officers as well as
other employees and individuals against expenses (including attorneys' fees),
judgments, fines and amounts paid in settlement in connection with specified
actions, suits or proceedings, whether civil, criminal, administrative or
investigative (other than an action by or in the right of the corporation - a
"derivative action"), if they acted in good faith and in a manner they
reasonably believed to be in or not opposed to the best interests of the
corporation and, with respect to any criminal action or proceedings, had no
reasonable cause to believe their conduct was unlawful. A similar standard
is applicable in the case of derivative actions, except that indemnification
only extends to expenses (including attorneys' fees) actually and reasonably
incurred in connection with the defense or settlement of such action, and the
statute requires court approval before there can be any indemnification where
the person seeking indemnification has been found liable to the corporation.
The statute provides that it is not exclusive of other indemnification that
may be granted by a corporation's by laws, disinterested director vote,
stockholder vote, agreement or otherwise.
Under the terms of the Company's Bylaws and subject to the applicable
provisions of the laws of the State of Delaware, the Company has indemnified
each of its directors and officers, and any employee of the Company who, at
the Company's request, has served as a director or officer of another
corporation in which the Company owns capital or of which it is a creditor,
against expenses incurred or paid in connection with any claim made against
such director or officer or any actual or threatened action, suit or
proceeding in which such director or officer may be involved by reason of
being or having been a director or officer of the Company, or of serving or
having served at the request of the Company as a director, officer, employee
or agent of another corporation, partnership, joint venture, trust or other
enterprise, or by reason of any action taken or not taken by such director or
officer in such capacity, and against the amount or amounts paid by such
director or officer in settlement of any such claim, action, suit or
proceeding or any judgment or order entered therein.
Section 102(b)(7) of the DGCL permits a provision in the certificate of
incorporation of each corporation organized thereunder, such as the Company,
eliminating or limiting, with certain exceptions, the personal liability of a
director to the corporation or its stockholders for monetary
2
<PAGE>
damages for breach of fiduciary duty as a director. The Restated Certificate
of Incorporation of the Company eliminates the liability of directors to the
extent permitted by the DGCL.
The Company carries directors' and officers' liability insurance that
covers certain liabilities and expenses of the Company's directors and
officers.
Item 7. Exemption from Registration Claimed.
Not applicable.
Item 8. Exhibits.
Exhibit Number Description
-------------- -----------
4(a) - Restated Certificate of Incorporation of Bristol-Myers Squibb
Company (filed as Exhibit 4(a) to the Registrant's
Registration Statement on Form S-3, Registration No. 33-33682,
dated March 7, 1990).<f*>
4(b) - Bylaws of the Registrant, as amended through February 3, 1993,
(filed as Exhibit 3b to the Registrant's Annual Report on Form
10-K, File No. 1-1136, for the fiscal year ended December 31,
1992.)<f*>
4(c) - Rights Agreement dated as of December 4, 1987, between the
Registrant and Rights Agent named therein, as amended (filed
as Exhibit 1 to the Registrant's Registration Statement on
Form 8-A, File No. 1-1136, dated December 7, 1987),<f*> as
amended by Amendment No. 1 (filed as Exhibit 1 to the
Registrant's Form 8; File No. 1-1136, dated July 27,
1989).<f*>
5 - Opinion of the Registrant's General Counsel as to the legality
of securities offered under Bristol-Myers Squibb Company 1983
Stock Option Plan (As Amended and Restated as of January 1,
1993).
23(a) - Consent of Independent Accountants, Price Waterhouse.
23(b) - Consent of Counsel (contained in the Opinion of the
Registrant's General Counsel, Exhibit 5 hereto.)
24 - Certified resolutions of the Board of Directors of Bristol-
Myers Squibb Company and related Power of Attorney.
- ------------------------------
[FN]
<f*> Incorporated by reference
3
<PAGE>
Item 8. Exhibits (continued).
Exhibit Number
--------------
99 - Bristol-Myers Squibb Company 1983 Stock Option Plan (as
amended and restated as of January 1, 1993) as amended through
September 14, 1993.
Item 9. Undertakings.
(1) The undersigned Registrant hereby undertakes:
(a) to file, during any period in which offers or sales are being
made, a post-effective amendment to this Registration Statement:
(i) To include any prospectus required by Section 10(a)(3) of
the Securities Act of 1933;
(ii) To reflect in the prospectus any facts or events arising
after the effective date of the Registration Statement (or the most
recent post-effective amendment thereof) which, individually or in the
aggregate, representa fundamental change in the information set forth in
the Registration Statement;
(iii) To include any material information with respect to the
plan of distribution not previously disclosed in the Registration
Statement or any material change to such information in the Registration
Statement;
Provided, however, that paragraphs (1)(a)(i) and (1)(a)(ii) do not
apply if the registration statement is on Form S-3 or Form S-8 and the
information required to be included in a post-effective amendment by those
paragraphs are contained in periodic reports filed by the Registrant pursuant
to Section 13(a) or Section 15(d) of the 1934 Act that are incorporated by
reference in the registration statement.
(b) That, for the purpose of determining any liability under the
Securities Act of 1933, each such post-effective amendment shall be deemed to
be a new Registration Statement relating to the securities offered therein,
and the offering of such securities at that time shall be deemed to be the
initial bona fide offering thereof.
(c) To remove from registration by means of a post-effective
amendment any of the securities being registered which remain unsold at the
termination of the offering.
(2) The undersigned Registrant hereby undertakes that, for the purpose
of determining any liability under the Securities Act of 1933, each filing of
the issuer's annual report pursuant to Section 13(a) or 15(d) of the
Securities Exchange Act of 1934 (and, where applicable, each filing of an
employee benefit plan's annual report pursuant to Section 15(d) of the
Securities Exchange Act of 1934) that is incorporated by reference in the
Registration Statement shall be deemed to be a new Registration Statement
relating to the securities offered therein and the offering of such
securities at the time shall be deemed to be the initial bona fide offering
hereof.
4
<PAGE>
(3) Insofar as indemnification for liabilities arising under the
Securities Act of 1933 may be permitted to directors, officers and
controlling persons of the Registrant pursuant to the foregoing provisions,
or otherwise, the Registrant has been advised that in the opinion of the
Commission such indemnification is against public policy as expressed in the
Act and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the
Registrant of expenses incurred or paid by a director, officer or controlling
person of the Registrant in the successful defense of any action, suit or
proceeding) is asserted by such director, officer or controlling person in
connection with the securities being registered, the Registrant will, unless
in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in the Act
and will be governed by the final adjudication of such issue.
EXPERTS
The financial statements incorporated in the Prospectus constituting
part of this Registration Statement by reference to the Annual Report on Form
10-K of Bristol-Myers Squibb Company for the year ended December 31, 1992,
have been so incorporated in reliance on the report of Price Waterhouse,
independent accountants, given on the authority of said firm as experts in
auditing and accounting.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form S-8 and has duly caused the
Registration Statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of New York, and the State of New
York, on the 16th day of March, 1994.
BRISTOL-MYERS SQUIBB COMPANY
By: *
---------------------------------------
(Charles A. Heimbold, Jr.,
President, Chief Executive Officer
and Director)
5
<PAGE>
Pursuant to the requirements of the Securities Act of 1933, the
Registration Statement has been signed below by the following persons in the
capacities indicated and on the 16th day of March, 1994.
Signature Title
_________ _____
* President, Chief Executive Officer and
- -------------------------- Director
(Charles A. Heimbold, Jr.) (Principal Executive Officer)
* Executive Vice President, Chief Financial
- -------------------------- Officer and Director (Principal Financial
(Michael E. Autera) Officer)
Corporate Staff Vice President and
- -------------------------- Controller (Principal Accounting Officer)
(Frederick S. Schiff)
* Chairman of the Board of Directors
- --------------------------
(Richard L. Gelb)
* Director
- --------------------------
(Robert E. Allen)
* Director
- --------------------------
(Ellen V. Futter)
* Director
- --------------------------
(Louis V. Gerstner, Jr.)
* Director
- --------------------------
(John D. Macomber)
* Director
- --------------------------
(Alexander Rich, M.D.)
* Director
- --------------------------
(James D. Robinson III)
* Director
- --------------------------
(Andrew C. Sigler)
* Director
- --------------------------
(Lewis W. Sullivan, M.D.)
* The undersigned, by signing her name hereto, does hereby sign this
registration statement or amendment thereto on behalf of each of the
above-indicated directors or officers of Bristol-Myers Squibb Company
pursuant to powers of attorney executed by each such director or
officer.
/s/ Pamela D. Kasa
- ----------------------------------
(Pamela D. Kasa, Attorney-in-fact)
6
<PAGE>
Registration No. 33-
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-------------------------
EXHIBITS
filed with
Form S-8
Registration Statement
Under
The Securities Act of 1933
-------------------------
Bristol-Myers Squibb Company 1983 Stock Option Plan
(as Amended and Restated as of January 1, 1993)
(Full title of Plan)
BRISTOL-MYERS SQUIBB COMPANY
(Exact name of Issuer as specified in its charter)
<PAGE>
Bristol-Myers Squibb Company
-------------------------
Exhibit Index
Exhibit Sequential
Number Description Page Number
- ------- ----------- -----------
4(a) Restated Certificate of Incorporation of Bristol-Myers
Squibb Company (filed as Exhibit 4(a) to the Registrant's
Registration Statement on Form S-3, Registration No. 33-
33682, dated March 7, 1990). *
4(b) Bylaws of the Registrant, as amended through February 3,
1993, (filed as Exhibit 3b to the Registrant's Annual
Report on Form 10-K, File No. 1-1136, for the fiscal year
ended December 31, 1992.) *
4(c) Rights Agreement dated as of December 4, 1987, between
the Registrant and the Rights Agent named therein, as
amended (filed as Exhibit 1 to the Registrant's
Registration Statement on Form 8-A, File No. 1-1136,
dated December 7, 1987), as amended by Amendment No. 1
(filed as Exhibit 1 to the Registrant's Form 8, File No.
1-1136, dated July 27, 1989). *
5 Opinion of the Registrant's General Counsel as to the
legality of securities offered under Bristol-Myers Squibb
Company 1983 Stock Option Plan (As Amended and Restated
as of January 1, 1993).
23(a) Consent of Independent Accountants, Price Waterhouse.
23(b) Consent of Counsel (contained with the Opinion of the
Registrant's General Counsel, Exhibit 5 hereto.)
- -----------------------------------
* Incorporated by reference.
2
<PAGE>
Bristol-Myers Squibb Company
----------------------------
Exhibit Index, continued
Exhibit Sequential
Number Description Page Number
- ------- ----------- -----------
24 Certified resolutions of the Board of Directors of
Bristol-Myers Squibb Company and related Power of
Attorney.
99 Bristol-Myers Squibb Company 1983 Stock Option Plan (as
amended and restated as of January 1, 1993) as amended
through September 14, 1993.
3
Exhibit 5
[Letterhead of Bristol-Myers Squibb Company]
March 11, 1994
Bristol-Myers Squibb Company
345 Park Avenue
New York, New York 10154
Re: Bristol-Myers Squibb Company - Registration Statement on Form
S-8 relating to the Bristol-Myers Squibb Company 1983 Stock
Option Plan (As Amended and Restated as of January 1, 1993)
(the "Registration Statement")
-------------------------------------------------------------
Gentlemen:
In connection with proposed sale of up to 15,000,000 of the common
stock par value $.10 (the "Shares") of Bristol-Myers Squibb Company (the
"Company") pursuant to the Bristol-Myers Squibb Company 1983 Stock Option
Plan (As Amended and Restated as of January 1, 1993) (the "Plan") with
respect to which a Registration Statement on Form S-8 has been prepared for
filing with the Securities and Exchange Commission pursuant to the Securities
Act of 1933, I have examined or supervised the examination of such corporate
records, other documents and questions of law as I considered necessary for
the purposes of this opinion.
I am of the opinion that when:
(a) the applicable provisions of the Securities Act of 1933 and of
State securities "blue sky" laws shall have been complied with;
(b) the Company's Board of Directors shall have duly authorized
the issue and sale of the Shares; and
(c) the Shares shall have been duly issued and paid for (in an
amount not less than $.10 par value thereof);
the Shares will be legally issued, fully paid and nonassessable.
I hereby consent to the use of this opinion as an Exhibit to the
Registration Statement on Form S-8 and to the reference to me under the
caption "Legal Opinion" in the Registration Statement and related prospectus,
and any amendments thereto, filed or distributed in connection with the Plan.
Very truly yours,
/s/ Rodolphe Hamel
------------------------------
Rodolphe Hamel
General Counsel
Exhibit 23(a)
CONSENT OF INDEPENDANT ACCOUNTANTS
We hereby consent to the incorporation by refence in the Prospectus
constituting part of the Registration Statement on Form S-8 of our report dated
January 21, 1993, which appears on page 39 of the 1992 Annual Report to
Shareholders of Bristol-Myers Squibb Company, which is incorporated by reference
in Bristol-Myers Squibb Company's Annual Report on Form 10-K for the year ended
December 31, 1992. We also consent to the incorporation by reference of our
report on the Financial Statement Schedules, which appears on page 17 of such
Annual Report on Form 10-K. We also consent to the reference to us under the
heading "Experts" in such Prospectus.
/s/ Price Waterhouse
PRICE WATERHOUSE
New York, New York
March 15, 1994
Exhibit 24
CERTIFICATION
-------------
I, Pamela D. Kasa, Secretary of Bristol-Myers Squibb Company (the
"Company"), a corporation organized under the laws of the State of Delaware,
hereby certify that the following is a true and exact copy of a resolution
taken from the minutes of a regular meeting of the Board of Directors of said
corporation, held at the offices of the Company, 345 Park Avenue, New York,
New York, on the 2nd day of March, 1993.
RESOLVED, that effective January 1, 1993,
the Bristol-Myers Squibb Company 1983 Stock
Option Plan be, and hereby is, amended as set
forth in Exhibit E attached to these minutes.
IN WITNESS WHEREOF, I have hereunto placed my hand and the seal of
the corporation on this 11th day of March, 1994.
/s/ Pamela D. Kasa
-------------------------------
Secretary
<PAGE>
EXHIBIT E
Board Resolutions
BRISTOL-MYERS SQUIBB COMPANY
----------------------------
1983 Stock Option Plan
(As Amended and Restated as of January 1, 1993)
RESOLVED, that the 1983 Stock Option Plan (as amended and restated
as of January 1, 1993) (the "Plan") of Bristol-Myers Squibb Company (the
"Company") in substantially the form presented to this meeting is hereby
adopted effective January 1, 1983, with such changes therein as the
designated officers (as defined below) of the Company deem necessary or
desirable, such effectiveness to be subject to the approval of the
shareholders of the Company at the next annual meeting of shareholders; and
RESOLVED, that the adoption of said Plan is hereby declared to be
advisable; and
RESOLVED, that said Plan be submitted to the stockholders of this
Company entitled to vote thereon at the Annual Meeting of Stockholders to be
held May 4, 1993, with a recommendation that the same be approved and that
its adoption by this Board of Directors be authorized; and
RESOLVED, that the Chairman, the President, any Executive Vice
President, any Senior Vice President, any Vice President or the Secretary of
the Company ("designated officers") are each authorized and empowered (a) to
certify these resolutions to any person and (b) to execute all other
documents and certifications in order to comply with the legal and other
<PAGE>
requirements pertaining to the Plan or otherwise to carry out the purposes
and intent of the foregoing resolution; and
RESOLVED, that upon approval of the Plan by shareholders, a number
of shares of the Company's Common Stock (par value $.10 per share) equal to
0.9% of the outstanding shares of the Company's Common Stock on January 1,
1993 be and hereby are reserved for issuance from time to time for offering
under and pursuant to the Plan, and, upon the issuance and sale of said
shares pursuant to the Plan, said shares will be fully paid and non-
assessable by the Company; and
RESOLVED, that on January 1, 1994 and on January 1 of each
succeeding year of the ten-year term of the Plan an additional number of
shares of the Company's Common Stock (par value $.10 per share) equal to 0.9%
of the outstanding shares of the Company's Common Stock (par value $.10 per
share) on such date be, and hereby are, reserved for issuance from time to
time for offering under and pursuant to the Plan, and, upon the issuance and
sale of said shares pursuant to the Plan, said shares will be fully paid and
nonassessable by the Company; and
RESOLVED, that the preparation and filing of a registration
statement on Form S-8 under the Securities Act of 1933 for the registration
of the shares of the Company's Common Stock to be issued pursuant to the Plan
is hereby approved and that each of the designated officers of the Company is
hereby authorized and empowered to execute said registration statement on
behalf of the Company and to cause the same to be filed with the Securities
and Exchange Commission (the "Commission"); and
- 2 -
<PAGE>
RESOLVED, that each of the designated officers is authorized and
empowered to execute and file all such instruments and documents, make all
payments and do all such other acts and things, including the execution and
filing of an amendment or amendments to said registration statement, as such
officer may deem necessary or desirable in order to effect such filing and
procure the effectiveness of said registration statement; and
RESOLVED, that, for the purpose of executing the registration
statement and causing the same to be filed with the Commission and of
remedying any deficiencies or making any changes with respect thereto by an
appropriate amendment or amendments, the directors and officers of the
Company be, and each of them hereby is, authorized and empowered to give
their several powers of attorney to Rodolphe Hamel, and Pamela D. Kasa, or
any one of them; and that the power of attorney, in the form presented to
this meeting, be, and it hereby is, approved with such changes therein as the
designated officers, or any one of them, may deem necessary or desirable; and
RESOLVED, that it is desirable and in the best interest of the
Company that its securities be qualified or registered for sale in various
states; that the designated officers are each authorized to determine the
states in which appropriate action shall be taken to qualify or register for
sale all or such part of the shares of the Company's Common Stock (par value
$.10 per shares) to be issued under the Plan, as the designated officers may
deem necessary or advisable; that each of the designated officers are hereby
authorized to perform on behalf of the
- 3 -
<PAGE>
Company any and all such acts as they may deem necessary or advisable in
order to comply with the applicable laws of any such states, and in
connection therewith to execute and file all requisite papers and documents,
including, but not limited, to applications, reports, surety bonds,
irrevocable consents and appointments of attorneys for service of process;
and the execution by the designated officers of any such paper or documents
or the doing by them of any act in connection with the foregoing matters
shall conclusively establish their authority therefor from the Company and
the approval and ratification by the Company of the papers and documents so
executed and the action so taken; and
RESOLVED, that the designated officers are each authorized and
directed on behalf of the Company to prepare, execute and cause to be filed
with the New York Stock Exchange, Inc., and the Pacific Stock Exchange,
Incorporated, applications for the listing of the shares of the Company's
Common Stock, par value $.10 per share, to be issued under the Plan, and to
execute and file such documents and instruments and to take any and all such
action in connection therewith, including the execution and filing of such
amendment or amendments, supplement or supplements, exhibit or exhibits
thereto, as the designated officers may deem necessary or desirable; and
RESOLVED, that the designated officers are each authorized to
appear before the New York Stock Exchange, Inc. and the Pacific Stock
Exchange, Incorporated, with authority to make such changes in the
application filed with each such Exchange, or
- 4 -
<PAGE>
in the exhibits, agreements or instruments relating thereto, and to do such
other acts and things as they may deem necessary or desirable to conform to
the requirements for listing on each such Exchange.
- 5 -
<PAGE>
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that each person whose signature
appears below constitutes and appoints Rodolphe Hamel, and Pamela D. Kasa and
each of them severally, that person's true and lawful attorney-in-fact, with
power to act with or without the others, and with power of substitution and
resubstitution, to execute in that person's name, place and stated in that
person's capacity as a Director or officer of Bristol-Myers Squibb Company
any and all amendments to a Registration Statement on Form S-8 relating to
the Bristol-Myers Squibb Company 1983 Stock Option Plan (as amended and
restated as of January 1, 1993), with exhibits thereto, and all documents
necessary or incidental in connection therewith, and to file the same with
the Securities and Exchange Commission, hereby ratifying and confirming all
that each of said attorney-in-fact, or their substitutes, may do or cause to
be done by virtue hereof.
/s/ Robert E. Allen
- ----------------------------------- June 29, 1993
ROBERT E. ALLEN
/s/ Michael E. Autera
- ----------------------------------- June 23, 1993
MICHAEL E. AUTERA
<PAGE>
/s/ Ellen V. Futter
- ----------------------------------- June 29, 1993
ELLEN V. FUTTER
/s/ Richard L. Gelb
- ----------------------------------- June 28, 1993
RICHARD L. GELB
/s/ Louis V. Gerstner, Jr.
- ----------------------------------- June 31, 1993
LOUIS V. GERSTNER, JR.
/s/ Charles A. Heimbold, Jr.
- ----------------------------------- June 21, 1993
CHARLES A. HEIMBOLD, JR.
/s/ John D. Macomber
- ----------------------------------- June 18, 1993
JOHN D. MACOMBER
/s/ Alexander Rich, M.D.
- ----------------------------------- June 15, 1993
ALEXANDER RICH, M.D.
/s/ James D. Robinson, III
- ----------------------------------- June 29, 1993
JAMES D. ROBINSON, III
/s/ Andrew C. Sigler
- ----------------------------------- July 12, 1993
ANDREW C. SIGLER
/s/ Louis W. Sullivan, M.D.
- ----------------------------------- June 11, 1993
LOUIS W. SULLIVAN, M.D.
- 2 -
<PAGE>
Exhibit 99
BRISTOL-MYERS SQUIBB COMPANY
1983 STOCK OPTION PLAN
(As Amended and Restated effective January 1, 1993)
(As Amended to September 14, 1993)
1. Purpose: The purpose of the 1983 Stock Option Plan (as amended
and restated as of January 1, 1993) (the "Plan") is to secure for the Company
and its stockholders the benefits of the incentive inherent in common stock
ownership by the officers and key employees of the Company and its
Subsidiaries and Affiliates who will be largely responsible for the Company's
future growth and continued financial success and by providing long-term
incentives in addition to current compensation to certain key executives of
the Company and its Subsidiaries and Affiliates who contribute significantly
to the long-term performance and growth of the Company and such Subsidiaries
and Affiliates. It is intended that the former purpose will be effected
through the grant of stock options and stock appreciation rights under the
Plan and that the latter purpose will be effected through an award
conditionally granting performance units under the Plan, either independently
or in conjunction with and related to a nonqualified stock option grant under
the Plan. The Bristol-Myers Squibb Company Long-Term Performance Award Plan
(as amended to January 17, 1983 and in effect as of December 31, 1992)
("LTPAP") has been merged into and consolidated with the Plan as of January
1, 1993. As used herein, the term "Prior Plan" shall mean the Bristol-Myers
Squibb Company 1983 Stock Option Plan (as amended through May 1, 1991 and in
effect as of December 31, 1992) prior to its amendment and restatement as of
January 1, 1993.
2. Definitions: For purposes of this Plan:
(a) "Affiliate" shall mean any entity in which the Company has an
ownership interest of at least 20%.
(b) "Code" shall mean the Internal Revenue Code of 1986, as
amended.
(c) "Common Stock" shall mean the Company's common stock (par
value $.10 per share).
(d) "Company" shall mean Bristol-Myers Squibb Company.
(e) "Disability" or "Disabled" shall mean qualifying for and
receiving payments under a disability pay plan of the Company or any
Subsidiary or Affiliate.
(f) "Exchange Act" shall mean the Securities Exchange Act of 1934,
as amended.
(g) "Fair Market Value" shall mean the average of the high and low
sales prices of a share of Common Stock on the New York Stock Exchange, Inc.
composite tape on the date of measurement or on any date as determined by the
Committee and if there were no trades on such date, on the day on which a
trade occurred next preceding such date.
(h) "Retirement" shall mean termination of the employment of an
employee with the Company or a Subsidiary or Affiliate on or after (i) the
employee's 65th birthday or (ii) the employee's 55th birthday if the employee
has completed 10 years of service with the Company, its Subsidiaries and/or
its Affiliates.
Furthermore, an employee who makes no election to retire under
Article 19 of the Bristol-Myers Squibb Company Retirement Income Plan (the
"Retirement Income Plan") shall have any additional years of age and service
which are credited under Article 19 of the Retirement Income Plan taken into
account when determining such employee's age and service under this Section
2(h). Such election shall be deemed a Retirement for purposes of this
Section 2(h) and all other purposes of this Plan.
(i) "Subsidiary" shall mean any corporation which at the time
qualifies as a subsidiary of the Company under the definition of "subsidiary
corporation" in Section 424 of the Code.
<PAGE>
3. Amount of Stock: The amount of stock which may be made subject
to grants of options or awards of performance units under the Plan in
calendar year 1993 shall not exceed an amount equal to (i) 0.9% of the
outstanding shares of the Company's Common Stock on January 1, 1993, plus
(ii) the amount of shares available for, and not made subject to, grants of
options under the Prior Plan as of January 1, 1993, less (iii) the number of
shares subject to options granted in 1993 under the Prior Plan and (iv) the
number of shares corresponding to awards of performance units outstanding
under the LTPAP on the date the Plan is approved by the stockholders of the
Company. With respect to each succeeding year, the amount of stock which may
be made subject to grants of options or awards of performance units under the
Plan shall not exceed an amount equal to (i) 0.9% of the outstanding shares
of the Company's Common Stock on January 1 of such year plus, subject to this
Section 3, (ii) in any year the number of shares equal to the amount of
shares that were available for grants and awards in the prior year but were
not made subject to a grant or award in such prior year and (iii) the number
of shares that were subject to options or awards granted hereunder or under
the Prior Plan, which options or awards terminated or expired in the prior
year without being exercised. Common Stock issued hereunder may be
authorized and reissued shares or issued shares acquired by the Company or
its Subsidiaries on the market or otherwise.
4. Administration: The Plan shall be administered under the
supervision of the Board of Directors of the Company which shall exercise its
powers, to the extent herein provided, through the agency of a Compensation
and Management Development Committee (the "Committee") which shall be
appointed by the Board of Directors of the Company and shall consist of not
less than three directors who shall serve at the pleasure of the Board. No
member of the Committee shall have been within one year prior to appointment
to, or while serving on, the Committee granted or awarded equity securities
of the Company pursuant to this or any other plan of the Company or its
Subsidiaries or Affiliates except to the extent that participation in any
such plan or receipt of any such grant or award would not adversely affect
the Committee member's status as a disinterested person for purposes of Rule
16b-3 under the Exchange Act.
The Committee, from time to time, may adopt rules and regulations
for carrying out the provisions and purposes of the Plan and make such other
determinations, not inconsistent with the terms of the Plan, as the Committee
shall deem appropriate. The interpretation and construction of any provision
of the Plan by the Committee shall, unless otherwise determined by the Board
of Directors, be final and conclusive.
The Committee shall maintain a written record of its proceedings.
A majority of the Committee shall constitute a quorum, and the acts of a
majority of the members present at any meeting at which a quorum is present,
or acts unanimously approved in writing, shall be the acts of the Committee.
5. Eligibility: Options and awards may be granted only to present
or future officers and key employees of the Company and its Subsidiaries and
Affiliates, including Subsidiaries and Affiliates which become such after the
adoption of the Plan. Any officer of key employee of the Company or of any
such Subsidiary or Affiliate shall be eligible to receive one or more options
or awards under the Plan. Any director who is not an officer or employee of
the Company or one of its Subsidiaries or Affiliates and any member of the
Committee, during the time of the member's service as such or thereafter,
shall be ineligible to receive an option or award under the Plan. The
adoption of this Plan shall not be deemed to give any officer or employee any
right to an award or to be granted an option to purchase Common Stock of the
Company, except to the extent and upon such terms and conditions as may be
determined by the Committee.
6. Stock Options: Stock options under the Plan shall consist of
incentive stock options under Section 422 of the Code or nonqualified stock
options (options not intended to qualify as incentive stock options), as the
Committee shall determine. In addition, the Committee may grant stock
appreciation rights in conjunction with an option, as set forth in Section
6(b)(11), or may grant awards in conjunction with an option, as set forth in
Section 6(b)(10) (as "Associated Option").
Each option shall be subject to the following terms and conditions:
- 2 -
<PAGE>
(a) Grant of Options. The Committee shall (1) select the officers
and key employees of the Company and its Subsidiaries and Affiliates to whom
options may from time to time be granted, (2) determine whether incentive
stock options or nonqualified stock options, are to be granted, (3) determine
the number of shares to be covered by each option so granted, (4) determine
the terms and conditions (not inconsistent with the Plan) of any option
granted hereunder (including but not limited to restrictions upon the
options, conditions of their exercise, or on the shares of Common Stock
issuable upon exercise thereof), (5) determine whether nonqualified stock
options or incentive stock options granted under the Plan shall include stock
appreciation rights and, if so, shall determine the terms and conditions
thereof in accordance with Section 6(b)(11) hereof, (6) determine whether any
nonqualified stock options granted under the Plan shall be Associated
Options, and (7) prescribe the form of the instruments necessary or advisable
in the administration of options.
(b) Terms and Conditions of Option. Any option granted under the
Plan shall be evidenced by a Stock Option Agreement executed by the Company
and the optionee, in such form as the Committee shall approve, which
agreement shall be subject to the following terms and conditions and shall
contain such additional terms and conditions not inconsistent with the Plan,
and in the case of an incentive stock option not inconsistent with the
provisions of the Code applicable to incentive stock options, as the
Committee shall prescribe:
(1) Number of Shares Subject to an Option. The Stock Option
Agreement shall specify the number of shares of Common Stock subject to
the Agreement. If the option is an Associated Option, the number of
shares of Common Stock subject to such Associated Option shall initially
be equal to the number of performance units subject to the award, but
one share of Common Stock shall be canceled for each performance unit
paid out under the award.
(2) Option Price. The purchase price per share of Common Stock
purchasable under an option will be determined by the Committee but will
be not less than the Fair Market Value of a share of Common Stock on the
date of the grant of such option.
(3) Option Period. The period of each option shall be fixed by
the Committee, but no option shall be exercisable after the expiration
of ten years from the date the option is granted.
(4) Consideration. Each optionee, as consideration for the grant
of an option, shall remain in the continuous employ of the Company or of
one of its Subsidiaries or Affiliates for at least one year from the
date of the granting of such option, and no option shall be exercisable
until after the completion of such one year period of employment by the
optionee.
(5) Exercise of Option. An option may be exercised in whole or in
part from time to time during the option period (or, if determined by
the Committee, in specified installments during the option period) by
giving written notice of exercise to the Company specifying the numbers
of shares to be purchased, such notice to be accompanied by payment in
full of the purchase price and Withholding Taxes (as defined in Section
10 hereof) due either by certified or bank check, or in shares of Common
Stock of the Company owned by the optionee having a Fair Market Value at
the date of exercise equal to such purchase price and Withholding Taxes
due, or in a combination of the foregoing; provided, however, that
payment in shares of Common Stock of the Company will not be permitted
unless at least 100 shares of Common Stock are required and delivered
for such purpose. No shares shall be issued until full payment therefor
has been made. An optionee shall have the rights of a stockholder only
with respect to shares of stock for which certificates have been issued
to the optionee.
(6) Nontransferability of Options. No option or stock
appreciation right granted under the Plan shall be transferable by the
optionee otherwise than by will or by the laws of descent and
distribution, and such option or stock appreciation right shall be
exercisable, during the optionee's lifetime, only by the optionee.
- 3 -
<PAGE>
(7) Retirement and Termination of Employment Other than by Death
or Disability. If an optionee shall cease to be employed by the Company
of any of its Subsidiaries and Affiliates for any reason (other than
termination of employment by reason of death or Disability) after the
optionee shall have been continuously so employed for one year after the
granting of the option, the option shall be exercisable only to the
extent that the optionee was otherwise entitled to exercise it at the
time of such cessation of employment with the Company, Subsidiary or
Affiliate, but in no event after the expiration of the option period set
forth therein except that in the case of cessation of employment other
than by reason of Retirement or death, the option shall in no event be
exercisable after the date three months next succeeding such cessation
of employment. The Plan does not confer upon any optionee any right
with respect to continuation of employment by the Company or any of its
Subsidiaries or Affiliates.
(8) Disability of Optionee. An optionee who ceases to be employed
by reason of Disability shall be treated as though the optionee remained
in the employ of the Company or a Subsidiary or Affiliate until the
earlier of (i) cessation of payments under a disability pay plan of the
Company, Subsidiary or Affiliate, (ii) the optionee's death, or (iii)
the optionee's 65th birthday.
(9) Death of Optionee. In the event of the death of the optionee
while in the employ of the Company or of any of its Subsidiaries or
Affiliates or within whichever period after Retirement or cessation of
employment of the optionee specified in subsection (7) or (8) is
applicable, and provided the optionee shall have been continuously so
employed for one year after the granting of the option, the option shall
be exercisable by the executors, administrators, legatees or
distributees of the optionee's estate, as the case may be, at any time
following death but in no event after the expiration of the option
period set forth therein and only to the extent that the optionee would
otherwise have been entitled to exercise it if the optionee were then
living, except that in the case of the death of an optionee after
Retirement or other cessation of employment, the option shall in no
event be exercisable after the later of (i) the date twelve months next
succeeding such death or (ii) the last day of the period after
Retirement or other cessation of employment of the optionee specified in
Section 6(b)(7). In the event any option is exercised by the executors,
administrators, legatees or distributees of the estate of a deceased
optionee, the Company shall be under no obligation to issue stock
thereunder unless and until the Company is satisfied that the person or
persons exercising the option are the duly appointed legal
representatives of the deceased optionee's estate or the proper legatees
or distributees thereof.
(10) Long Term Performance Awards. The Committee may from time to
time grant nonqualified stock options under the Plan in conjunction with
and related to an award of performance units made under a Long Term
Performance Award as set forth in Section 7(b)(11). In such event,
notwithstanding any other provision hereof, (i) the number of shares to
which the Associated Option applies shall initially be equal to the
number of performance units granted by the award, but such number of
shares shall be reduced on a one share-for-one unit basis to the extent
that the Committee determines pursuant to the terms of the award, to pay
to the optionee or the optionee's beneficiary the performance units
granted pursuant to such award; and (ii) such Associated Option shall be
cancelable in the discretion of the Committee, without the consent of
the optionee, under the conditions and to the extent specified in the
award.
(11) Stock Appreciation Rights. In the case of any option granted
under the Plan, either at the time of grant or by amendment of such
option at any time after such grant there may be included a stock
appreciation right which shall be subject to such terms and conditions,
not inconsistent with the Plan, as the Committee shall impose, including
the following:
(A) A stock appreciation right shall be exercisable to the
extent, and only to the extent, that the option in which it is
included is at the time exercisable, and may be exercised within
such period only at such time or times as may be determined by the
Committee;
(B) A stock appreciation right shall entitle the optionee (or
any person entitled to act under the provisions of subsection (9)
hereof) to surrender unexercised the option in which the stock
appreciation right is included (or any portion of such option) to
the Company and to receive from the Company in exchange therefor
that number of shares having an aggregate value equal to (or, in
the
- 4 -
<PAGE>
direction of the Committee, less than) the excess of the value of
one share (provided such value does not exceed such multiple of the
option price per share as may be specified by the Committee) over
the option price per share specified in such option times the
number of shares called for the option, or portion thereof, which
is so surrendered. The Committee shall be entitled to cause the
Company to settlement its obligation, arising out of the exercise
of a stock appreciation right, by the payment of cash equal to the
aggregate value of the shares the Company would otherwise be
obligated to deliver or partly by the payment of cash and partly by
the delivery of shares. Any such election shall be made within 30
business days after the receipt by the Committee of written notice
of the exercise of the stock appreciation right. The value of a
share for this purpose shall be the Fair Market Value thereof on
the last business day preceding the date of the election to
exercise the stock appreciation right;
(C) No fractional shares shall be delivered under this
subsection (11) but in lieu thereof a cash adjustment shall be
made;
(D) If a stock appreciation right included in an option is
exercised, such option shall be deemed to have been exercised to
the extent of the number of shares called for by the option or
portion thereof which is surrendered on exercise of the stock
appreciation right and no new option may be granted covering such
shares under this Plan; and
(E) If an option which includes a stock appreciation right is
exercised, such stock appreciation right shall be deemed to have
been canceled to the extent of the number of shares called for by
the option or portion thereof is exercised and no new stock
appreciation rights may be granted covering such shares under this
Plan.
(12) Incentive Stock Options. In the case of any incentive stock
option granted under the Plan, the aggregate Fair Market Value of the
shares of Common Stock of the Company (determined at the time of grant
of each option) with respect to which incentive stock options granted
under the Plan and any other plan of the Company or its parent or a
Subsidiary which are exercisable for the first time by an employee
during any calendar year shall not exceed $100,000 or such other amount
as may be required by the Code. In any year, the maximum number of
shares with respect to which incentive stock options may be granted
shall not exceed 4,000,000 shares.
7. Long-term Performance Awards: Awards under the Plan shall
consist of the conditional grant to the participants of a specified number of
performance units. The conditional grant of a performance unit to a
participant will entitle the participant to receive a specified dollar value,
variable under conditions specified in the award, if the performance
objectives specified in the award are achieved and the other terms and
conditions thereof are satisfied.
Each award will be subject to the following terms and conditions:
(a) Grant of Awards. The Committee shall (1) select the officers
and key executives of the Company and its Subsidiaries and Affiliates to whom
awards may from time to time be granted, (2) determine the number of
performance units covered by each award, (3) determine the terms and
conditions of each performance unit awarded and the award period and
performance objectives with respect to each award, (4) determine the periods
during which a participant may request the Committee to approve deferred
payment of a percentage (50% or 100%) of an award (the "Deferred Portion")
and the interest or rate of return thereon or the basis on which such
interest or rate of return thereon is to be determined, (5) determine whether
payment with respect to the portion of an award which has not been deferred
(the "Current Portion") and the payment with respect to the Deferred Portion
of an award shall be made entirely in cash, entirely in Common Stock or
partially in cash and partially in Common Stock, (6) determine whether the
award is to be made independently of or in conjunction with a nonqualified
stock option granted under the Plan, and (7) prescribe the form of the
instruments necessary or advisable in the administration of the awards.
- 5 -
<PAGE>
(b) Term and Conditions of Award. Any award conditionally
granting performance units to a participant shall be evidenced by a
Performance Unit Agreement executed by the Company and the participant, in
such form as the Committee shall approve, which Agreement shall contain in
substance the following terms and conditions and such additional terms and
conditions as the Committee shall prescribe:
(1) Number of Performance Units. The Performance Unit Agreement
shall specify the number of performance units conditionally granted to
the participant. If the award has been made in conjunction with the
grant of an Associated Option, the number of performance units granted
shall initially be equal to the number of shares which the participant
is granted the right to purchase pursuant to the Associated Option, but
one performance unit shall be canceled for each share of the Company's
Common Stock purchased upon exercise of the Associated Option or for
each stock appreciation right included in such option that has been
exercised.
(2) Value of Performance Units. The Performance Unit Agreement
shall specify the threshold, target and maximum dollar values of each
performance unit and corresponding performance objectives as provided
Under Section 7(b)(5).
(3) Award Periods. For each award, the Committee shall designate
an award period with a duration to be determined by the Committee in its
discretion but in no event less than the three calendar years within
which specified performance objectives are to be attained. There may be
several award periods in existence at any one time and the duration of
performance objectives may differ from each other.
(4) Consideration. Each participant, as consideration for the
award of performance units, shall remain in the continuous employ of the
Company or of one of its Subsidiaries or Affiliates for at least one
year after the date of the making of such award, and no award shall be
payable until after the completion of such one year of employment by the
participant.
(5) Performance Objectives. The Committee shall establish
performance objectives with respect to the Company for each award period
on the basis of such criteria and to accomplish such objectives as the
Committee may from time to time determine. Performance objectives may
include objective and subjective criteria. During any award period, the
Committee may adjust the performance objectives for such award period as
it deems equitable in recognition of unusual or nonrecurring events
affecting the Company, changes in applicable tax laws or accounting
principles, or such other factors as the Committee may determine.
(6) Determination and Payment of Performance Units Earned. As
soon as practicable after the end of an award period, the Committee
shall determine the extent to which awards have been earned on the basis
of the Company's actual performance in relation to the established
performance objectives as set forth in the Performance Unit Agreement.
The Performance Unit Agreement shall specify that as soon as practicable
after the end of each award period, the Committee shall determine
whether the conditions of Sections 7(b)(4) and 7(b)(5) hereof have been
met and, if so, shall ascertain the amount payable to the participant in
respect of the performance units. As promptly as practicable after it
has determined that an amount is payable in respect of an award, the
Committee shall cause the Current Portion of such award to be paid to
the participant or the participant's beneficiaries, as the case may be,
in the Committee's discretion, either entirely in cash, entirely in
Common Stock or partially in cash and partially in Common Stock. The
Deferred Portion of an award shall be contingently credited and payable
to the participant over a deferred period and shall be credited with
interest or a rate of return, as determined by the Committee. The
Committee, in its discretion, shall determine the conditions upon, and
method of, payment of such deferred portions and whether such payment
will be made entirely in cash, entirely in Common Stock or partially in
cash and partially in Common Stock.
In making the payment of an award in Common Stock hereunder, the
cash equivalent of such Common Stock shall be determined by the Fair Market
Value of the Common Stock on the day the Committee designates the performance
units shall be paid.
- 6 -
<PAGE>
(7) Nontransferability of Awards and Designation of Beneficiaries.
No award under the Plan shall be transferable by the participant other
than by will or by the laws of descent and distribution, except that a
participant may designate a beneficiary pursuant to the provisions
hereof.
If any participant or the participant's beneficiary shall attempt
to assign the participant's rights under the Plan in violation of the
provisions thereof, the Company's obligation to make any further
payments to such participant or the participant's beneficiaries shall
forthwith terminate.
A participant may name one or more beneficiaries to receive any
payment of an award to which the participant may be entitled under the
Plan in the event of the participant's death, on a form to be provided
by the Committee. A participant may change the participant's
beneficiary designation from time to time in the same manner.
If no designated beneficiary is living on the date on which any
payment becomes payable to a participant's beneficiary, such payment
will be payable to the person or persons in the first of the following
classes of successive preference:
(i) Widow or widower, if then living,
(ii) Surviving children, equally,
(iii) Surviving parents, equally,
(iv) Surviving brothers and sisters, equally
(v) Executors or administrators
and the term "beneficiary" as used in the Plan shall include such person
or persons.
(8) Retirement and Termination of Employment Other Than by Death
or Disability. In the event of the Retirement prior to the end of an
award period of a participant who has satisfied the one year employment
requirement of Section 7(b)(4) with respect to an award prior to
Retirement, the participant, or his estate, shall be entitled to a
payment of such award at the end of the award period, pursuant to the
terms of the Plan and the participant's Performance Unit Agreement,
provided, however, that the participant shall be deemed to have earned
that proportion (to the nearest whole unit) of the value of the
performance units granted to the participant under such award as the
number of months of the award period which have elapsed since the first
day of the calendar year in which the award was made to the end of the
month in which the participant's Retirement occurs, bears to the total
number of months in the award period. The participant's rights in any
remaining performance units shall be canceled and forfeited.
Subject to Section 7(b)(6) hereof, the Performance Unit Agreement
shall specify that the rights of the participant in the performance
units granted to such participant shall be conditional and shall be
canceled, forfeited and surrendered if the participant's continuous
employment with the Company and its Subsidiaries and Affiliates shall
terminate for any reason, other than the participant's death, Disability
or Retirement prior to the end of the award period.
The Committee may, in its discretion, waive, in whole or in part,
the cancellation, forfeiture and surrender of any performance units.
(9) Disability of Participant. For the purposes of any award a
participant who becomes Disabled shall be deemed to have suspended
active employment by reason of Disability commencing on the date the
participant becomes entitled to receive payments under a disability pay
plan of the Company or any Subsidiary or Affiliate and continuing until
the date the participant is no longer entitled to receive such payments.
In the event a participant becomes Disabled during an award period but
only if the participant has satisfied the one year employment
requirement of Section 7(b)(4) with respect to an award prior to
becoming Disabled, upon the determination by the Committee of the extent
to which an award has been earned pursuant to Section 7(b)(6) the
participant shall be deemed to have earned that proportion (to the
nearest whole unit) of the value of the performance units granted to the
participants under such award as the number of months of the award
period
- 7 -
<PAGE>
in which the participant was not Disabled bears to the total number of
months of the award period. The participant's rights in any remaining
performance units shall be canceled and forfeited.
The Committee may, in its discretion, waive, in whole or in part,
such cancellation and forfeiture of any performance units.
(10) Death of Participant. In the event of the death prior to the
end of an award period of a participant who has satisfied the one year
employment requirement with respect to an award prior to the date of
death, the participant's beneficiaries or estate, as the case may be,
shall be entitled to a payment of such award upon the end of the award
period, pursuant to the terms of the Plan and the participant's
Performance Unit Agreement, provided, however, that the participant
shall be deemed to have earned that proportion (to the nearest whole
unit) of the value of the performance units granted to the participant
under such award as the number of months of the award period which have
elapsed since the first day of the calendar year in which the award was
made to the end of the month in which the participant's death occurs,
bears to the total number of months in the award period. The
participant's rights in any remaining performance units shall be
canceled and forfeited.
The Committee may, in its discretion, waive, in whole or in part,
such cancellation and forfeiture of any performance units.
(11) Grant of Associated Option. If the Committee determines that
the conditional grant of performance units under the Plan is to be made
to a participant in conjunction with the grant of a nonqualified stock
option under the Plan, the Committee shall grant the participant an
Associated Option under the Plan subject to the terms and conditions of
this subsection (11). In such event, such award under the Plan shall be
contingent upon the participant's being granted such an Associated
Option pursuant to which: (i) the number of shares the optionee may
purchase shall initially be equal to the number of performance units
conditionally granted by the award, (ii) such number of shares shall be
reduced on a one share-for-one unit basis to the extent that the
Committee determines, pursuant to Section 7(b)(6) hereof, to pay to the
participant or the participant's beneficiaries the performance units
conditionally granted pursuant to the award, and (iii) the Associated
Option shall be cancelable in the discretion of the Committee, without
the consent of the participant, under the conditions and to the extent
specified herein and in Section 7(b)(6) hereof.
If no amount is payable in respect of the conditionally granted
performance units, the award and such performance units shall be deemed
to have been canceled, forfeited and surrendered, and the Associated
Option, if any, shall continue in effect in accordance with its terms.
If any amount is payable in respect of the performance units and such
units were granted in conjunction with an Associated Option, the
Committee shall, within 30 days after the determination of the Committee
referred to in the first sentence of Section 7(b)(6), determine, in its
sole discretion, either:
(A) to cancel in full the Associated Option, in which event
the value of the performance units payable pursuant to Sections
7(b)(5) and (6) shall be paid;
(B) to cancel in full the performance units, in which event
no amount shall be paid to the participant in respect thereof but
the Associated Option shall continue in effect in accordance with
its terms; or
(C) to cancel some, but not all, of the performance units, in
which event the value of the performance units payable pursuant to
Sections 7(b)(5) and (6) which have not been canceled shall be paid
and the Associated Option shall be canceled with respect to that
number of shares equal to the number of conditionally granted
performance units that remain payable.
Any action taken by the Committee pursuant to the preceding
sentence shall be uniform with respect to all awards having the same
award period. If the Committee takes no such action, it shall be deemed
to have determined to cancel in full the award in accordance with clause
(B) above.
- 8 -
<PAGE>
8. Determination of Breach of Conditions. The determination of
the Committee as to whether an event has occurred resulting in a forfeiture
or a termination or reduction of the Company's obligations in accordance with
the provisions of the Plan shall be conclusive.
9. Adjustment in the Event of Change in Stock: In the event of
changes in the outstanding Common Stock of the Company by reason of stock
dividends, recapitalization, mergers, consolidations, split-ups, combinations
or exchanges of shares and the like, the aggregate number and class of shares
available under the Plan, and the number, class and the price of shares
subject to outstanding options and/or awards and the number of performance
units and/or the dollar value of each unit shall be appropriately adjusted by
the Committee, whose determination shall be conclusive.
10. Taxes: In connection with the transfer of shares of Common
Stock to an optionee, subject to Section 16 of the Exchange Act, as the
result of the exercise of a nonqualified stock option or a stock appreciation
right, or to a participant subject to Section 16 of the Exchange Act, upon
payment of an award, the Company shall have the right to retain or sell
without notice, or to demand surrender of, shares of Common Stock having a
Fair Market Value (taking into account any commissions or other expenses the
Company may incur upon the sale of such shares) on the date that the amount
required by any governmental entity to be withheld or otherwise deducted and
paid with respect to such transfer ("Withholding Tax") is to be determined
(the "Tax Date") sufficient to cover the amount of any Applicable Tax (the
amount of Withholding Tax plus the incremental amount determined on the basis
of the highest marginal tax rate applicable to such optionee or participant,
Federal Insurance Contribution Act taxes or other governmental impost or
levy), and to make payment (or to reimburse itself for payment made) to the
appropriate taxing authority of an amount in cash equal to the amount of such
Applicable Tax, remitting any balance to the optionee or participant.
As optionee or participant who is not an executive officer of the
Company subject to Section 16 of the Exchange Act shall be entitled to
satisfy the obligation to pay any Withholding Tax or Applicable Tax, by
providing the Company with funds sufficient to enable the Company to pay such
Withholding Tax or Applicable Tax or by requiring the Company to retain or to
accept upon delivery thereof by the optionee or participant shares of Common
Stock sufficient in value (determined in accordance with the last sentence of
the preceding paragraph), to cover the amount of such Withholding Tax or
Applicable Tax. Each election by an optionee or participant to have shares
retained or to deliver shares for this purpose shall be subject to the
following restrictions: (i) the election must be in writing and be made on or
prior to the Tax Date; (ii) the election must be irrevocable; (iii) the
election shall be subject to the disapproval of the Committee.
11. Amendment of the Plan: The Board of Directors may amend or
suspend the Plan at any time and from time to time. No such amendment of the
Plan may, however, increase the maximum number of shares to be offered under
options or awards, or change the manner of determining the option price, or
change the designation of employees or class of employees eligible to receive
options or awards, or permit the transfer or issue of stock before payment
therefor in full, or, without the written consent of the optionee or
participant, alter or impair any option or award previously granted under the
Plan, Prior Plan or LTPAP.
12. Amendment of Options Outstanding Under the Prior Plan: The
Prior Plan and certain nonqualified options granted and outstanding
thereunder are hereby amended to provide that any nonqualified option which
is outstanding on the date this Plan is adopted by a vote of the holders of a
majority of the shares of the Company's Common Stock and $2.00 Convertible
Preferred Stock present in person or by proxy at a duly held shareholders
meeting at which a quorum representing a majority of all outstanding voting
stock is present shall be exercisable in accordance with Sections 6(b)(7) and
6(b)(9), except that for the purpose of such options "Retirement" shall
additionally mean termination of the employment of an employee after
completing 35 years of service with the Company or its Subsidiaries.
Furthermore, an employee who makes an election to retire under
Article 19 of the Retirement Income Plan shall have any additional years of
age and service which are credited under Article 19 of the Retirement Income
Plan taken into account when determining such employee's age and years of
service with the Company or its Subsidiaries under this Section 12. Such
election shall be deemed a Retirement for purposes of this Section 12 and all
other purposes of this Plan.
- 9 -
<PAGE>
13. Miscellaneous: By accepting any benefits under the Plan, each
optionee or participant and each person claiming under or through such
optionee or participant shall be conclusively deemed to have indicated
acceptance and ratification of, and consent to, any action taken or made to
be taken or made under the Plan by the Company, the Board, the Committee or
any other Committee appointed by the Board. No participant or any person
claiming under or through him shall have any right or interest, whether
vested or otherwise, in the Plan or in any option, or stock appreciation
right or award thereunder, contingent or otherwise, unless and until all of
the terms, conditions and provisions of the Plan and the Agreement that
affect such participant or such other person shall have been complied with.
Nothing contained in the Plan or in any Agreement shall require the Company
to aggregate or earmark any cash or other property. Neither the adoption of
the Plan nor its operation shall in any way affect the rights and powers of
the Company or any of its Subsidiaries or Affiliates to dismiss and/or
discharge any employee at any time.
14. Term of the Plan: The Plan shall become effective as of
January 1, 1993 by action of the Board of Directors conditioned on and
subject to approval of the Plan, by a vote of the holders of a majority of
the shares of Common Stock and $2.00 Convertible Preferred Stock of the
Company present in person or by proxy at a duly held shareholders meeting at
which a quorum representing a majority of all outstanding voting stock is
present. The Plan shall terminate on December 31, 2002, or at such earlier
date as may be determined by the Board of Directors. Termination of the
Plan, however, shall not affect the rights of optionees under options
theretofore granted to them or the rights of participants under awards
theretofore granted to them, and all unexpired options and awards shall
continue in force and operation after termination of the Plan except as they
may lapse or be terminated by their own terms and conditions.
